Cullinan Therapeutics
CGEM | NASDAQ
$9.50
-$0.78 (-7.59%)
At close: Nov 16, 2026, 4:00 PM ET
$9.51
+$0.01 (+0.11%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Cullinan Therapeutics Statistics
Key statistics explainedMarket Data
$616.75M
$329.18M
-0.01
849.96K
64.6M
9.47%
N/A
NASDAQ
US2300311063
Price Performance
-26.5%
-53.9%
-36.1%
-8.2%
8.3%
8.0%
-51.7%
-26.5%
11.1%
-12.9%
-16.7%
Valuation
-2.91
N/A
-0.28
0.25
N/A
8.70
2.19
-3.73
-3.13
-3.71
N/A
-1.56
-1.56
-1.99
-34.4%
-26.8%
-32.0%
Financial Health
$289.57M
$2M
$289.57M
$322.56M
7.43
7.43
0.01
-0.01
-0.01
-82.56
0.00
5.21
1
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-19.2%
Returns
-63.1%
-59.1%
-77.2%
-77.5%
-63.1%
Historical Growth (CAGR)
N/A
-100.0%
N/A
-6.0%
-48.1%
N/A
-12.4%
-8.9%
N/A
Analyst Forecasts
Buy
3
5.0%
N/A
Mar 9, 2027
-$0.70
-9.1%
$13M
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$35.00
268.4%
Cash Flow
$-165.46M
$-165.47M
$-197.22M
-$2.56
-$2.56
0.0%
Income Statement
$0
$-53K
$-218.81M
$-210.48M
$-203.47M
-$3.27
N/A
$-1.87M
109
Add to Watchlist
Select watchlists to add or remove CGEM